Member Info for RuckRover

VD,

I'm reposting something I posted on 5th January. Perhaps you'd care to take note this time...

The other thing that gets on my tits is people moaning about BOD members not having "skin in the game".

The amount of money a director or senior executive wants to invest in their company(s) is entirely their personal choice. Their wealth management is no different to anyone else's and even though they may be a director of one company it is just as foolhardy to go "all in" on a single company as anyone else. They will undoubtedly have a diverse portfolio spread across different sectors like any other sensible investor.

The notion that a senior executive will do a better job if they have "skin in the game" is a complete fallacy. (As is the belief it will affect the SP). These are highly skilled professionals employed for their expertise in a specific area. Their remuneration is from salary, bonus and share options. If they fail to hit targets they do get their bonus and options. If they don't do a good job they will be fired.

The other thing people to fail to understand is the investments are relative. Lindy Durrant has 8 million shares - approximately 1% of the company. The CEO of HSBC has invested £1.2M of his own money yet this only amounts to 0.0012% of the issued share capital. Did LD buy these shares with her own money - yes. The money from share options earned as a result of great scientific discovery, hard work and commitment. In the early days of startups, founders raise modest funds from savings or remortgaging property - they take on ALL the risk. It is only right and proper that they should be rewarded, not at the ultimate end game but milestones along the way.

What I want to see is the CEO executing, the CSO advancing and proving the science and the CFO providing financial stability. The investment I want from investment funds who understand the investment and have deep pockets when required.

Ray,

Completely agree that the algorithms are extremely useful and constantly improving. However my point was that this is very different to AI.

Whether or not AI will prove useful in the biotech space remains to be seen. I suspect it will.

Ray,

There's a world of difference between a computer algorithm and AI. I'm not sure if Scancell have a CIO but I'm available if they want one. I'd settle for £120k plus share options. 😀

EE,

That’s good to know.

"Should Scancell look at adopting AI to fast track data into commercial probability. Just musing! "

Of course they should. The early adopters will get ahead, those that don't will be left behind.

Berm,

Too true LOL. If you didn't have patience to start, you will now.

Reminds me of....

“The stock market is a device for transferring money from the impatient to the patient.” Warren Buffett “Time is the friend of the wonderful business, the enemy of the mediocre.” One clear and simple investment edge that anyone can choose to take advantage of is patience.

Roses, "Cheer up, it’s not always as it seems in this game !"

True, it rarely is!

Well, you'd expect sales of that magnitude to have an even worse effect on the SP.

Obviously someone willing to mop up all the availability. Hope it's a big institutional investor.

Shivest,

You sound very bitter (and twisted)

Did you buy at 10.5p in an attack of FOMO and sell at 9p in a panic attack?

"If you knew for a fact there would be a placing tomorrow, you'd sell today."

Er, no I wouldn't and you have absolutely no idea what I or anyone else may or may not do.

shivest,

"hoping that down the line he can click some more buttons on a computer "

welcome to the digital age!

did you compose that by clicking buttons on a computer or do you have a direct input out of your ****?

Hang on a second. I know we are all frustrated at the current SP. I know many of us have been on a rollercoaster of elation and despair for a number of years. But some are beginning to lose sight of what this is all about.

It's about finding a cure, or at least, treatment for a dreadful disease. We have seen some impressive data on tumour shrinkage and 5 patients showing a complete response. This is bringing hope to patients who were previously in despair.

Does anyone REALLY think Scancell, the board and major investors are going to throw in the towel and abandon patients just because the SP is in the doldrums and there is a determined seller lurking? I think not.

After all, we are fully funded into H1 2026 - ample time to continue gathering and analysing data. Let's calm down and see what the next 6 months bring. And spare a thought for those truly on a roller coaster.

Scinv, thanks.

Scinv,

That is an interesting Chart.

Does anyone know why the patient with a 56% reductIon in tumour is colour coded progressive disease?

TF,

You're welcome. It is the 13th January 2025 update btw.

Https://www.trinitydelta.org/research-notes/poised-for-several-pivotal-clinical-events-in-2025/

EE,

You argue your case very eloquently.

EE,

"Since share price moves in the past provide no useful information about share price moves in the future,"

My word, someone's grumpy this morning!

Not entirely true. A highly volatile share that regularly moves up and down by a high percentage has a reasonably high probability of doing the same in the future. A share like Scancell that in 13 years only has a handful of jumps in the high teams is unlikely to treble overnight.

Past data is the basis of many forecasting techniques. If you base forecasts on inaccurate data the results will be questionable- garbage in, garbage out.

As eddy burke said "Those who don't know history are destined to repeat it,”

The same can be said about those with a distorted view of the past

It is the distorted view of reality that gives rise to stupid comments like "I wouldn't want to be out of this over the weekend"

Re. this earlier, "the 'valuation' discussion, surely it's time to point out, (not just to Violin), that before Scancell had, (a fraction of), what we've got now, Scancell SP went from 18p (?) to 64p (?), in just a few hours."

TF,

I'm not sure where this statement came from but it is quite untrue. There has never been a daily rise of this magnitude in the history of Scancell. For the fact lovers, here they are:

The Moditope discovery was announced on 15/08/2012. The intra-day high was 27.9p and it closed at 25.28- 40% up on the previous days close of 18.13p. As the news was absorbed, the SP closed at 39.75 3 days later before pulling back to the low 30s.

The intra-day high of 65.2p was reached on Monday 8th October 2012, up 14% from the previous close of 51p. There was no news during the days leading up to this nor any after other than a notice of results and a statement from the BOD saying they were unaware of any reason for the rise.

Other daily rises in excess of 50% are:

24/04/2020 up 52% (news Scancell are to develop a COVID vaccine)

15/02/2021 up 52.7% (no news)

11/04/2022 up 57.2% (Modi1 phase 1/2 trial open.

Those are the plain facts, I'll post an opinion separately.